$MANE
Veradermics, Incorporated
XNYS•Health Care•Pharmaceutical Preparations
Why is MANE down today? It is at $110.00 (-1.20%), and our scanner flagged it 66 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MANE spikes, and full due diligence on MANE — key stats, earnings, dilution and insider activity. Free.
Get free $MANE alerts the moment volume spikes
Our scanner flagged $MANE 66 times in the last 30 days. Create a free account to track $MANE, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $110.00
- Change today
- -1.20%
- Previous close
- $111.34
- 52-week range
- $32.00 – $131.24
- Market cap
- $4.65B
- Institutional own.
- 65.33%
- Total held
- 87.1%
- Tradeable float
- 5.4M 13% of shares · after 22% insiders + 65% institutions
- Short interest
- 3.9M ▲ +3% vs prior · as of 2026-07-15
- Short % of float
- 72.8%
- Days to cover
- 7.0d
- Avg daily volume
- 619K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNYS
- 5m
- 0.3x
- 15m
- 0.2x
- 1h
- 0.2x
- 1D
- 0.1x
Get free MANE + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $MANE down today?
MANE is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on MANE today.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
5 open-market buys0 buys, 0 sells last 3 months (15/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Suvretta Capital Management, Llc Director | Bought (open market) | +31K 0.07% of company | added 0.1% | 27.04M | $1.1M at $35.97 | Feb 6, 26 |
Waldman Reid Alexander Officer | Acquired (grant/award) | +1K | added 0.6% | 235K | n/a | Feb 5, 26 |
Durso Timothy August Officer | Acquired (grant/award) | +1K | added 1.3% | 118K | n/a | Feb 5, 26 |
Enright Patrick G Director | Acquired (grant/award) | +3.58M 8.6% of company | n/a | 2.41M | n/a | Feb 5, 26 |
Enright Patrick G Director | Bought (open market) | +1.07M 2.6% of company | added 30% | 4.65M | $18.3M at $17.00 | Feb 5, 26 |
Longitude Capital Partners V, Llc Beneficial Owner (10%) | Acquired (grant/award) | +3.58M 8.6% of company | n/a | 2.41M | n/a | Feb 5, 26 |
Longitude Capital Partners V, Llc Beneficial Owner (10%) | Bought (open market) | +1.07M 2.6% of company | added 30% | 4.65M | $18.3M at $17.00 | Feb 5, 26 |
Childs John W Director | Acquired (grant/award) | +1.91M 4.6% of company | n/a | 1.91M | n/a | Feb 5, 26 |
Childs John W Director | Bought (open market) | +294K 0.7% of company | added 15% | 2.20M | $5.0M at $17.00 | Feb 5, 26 |
Coric Vlad Director | Acquired (grant/award) | +521K 1.2% of company | n/a | 261K | n/a | Feb 5, 26 |
Coric Vlad Director | Acquired (grant/award) | +117K 0.3% of company | added 100% | 130K | n/a | Feb 5, 26 |
Coric Vlad Director | Bought (open market) | +118K 0.3% of company | added 23% | 639K | $2.0M at $17.00 | Feb 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $MANE runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $100.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$MANE Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$MANE Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to MANE
Comparable names in pharmaceutical preparations, closest in size first.
MANE stock FAQ
Why is $MANE down today?
MANE is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on MANE today.
What is the MANE stock price today?
MANE last traded at $110.00, down 1.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live MANE alerts?
The MANE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MANE 66 times in the last 30 days.
What exchange is MANE on?
MANE (Veradermics, Incorporated) trades on XNYS, with a market cap of about $4.65B in the PHARMACEUTICAL PREPARATIONS sector.
Is MANE good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MANE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.